Abstract:
The present disclosure relates to an electrical energy storage apparatus which forms an interpenetrating, three dimensional structure. The structure may have a first non-planar channel filled with an anode material to form an anode, and a second non-planar channel adjacent the first non-planar channel filled with a cathode material to form a cathode. A third non-planar channel may be formed adjacent the first and second non-planar channels and filled with an electrolyte. The first, second and third channels are formed so as to be interpenetrating and form a spatially dense, three dimensional structure. A first current collector is in communication with the first non-planar channel and forms a first electrode, while a second current collector is in communication with the second non-planar channel and forms a second electrode. A separator layers separates the current collectors.
Abstract:
The present disclosure relates to an electrical energy storage apparatus which forms an interpenetrating, three dimensional structure. The structure may have a first non-planar channel filled with an anode material to form an anode, and a second non-planar channel adjacent the first non-planar channel filled with a cathode material to form a cathode. A third non-planar channel may be formed adjacent the first and second non-planar channels and filled with an electrolyte. The first, second and third channels are formed so as to be interpenetrating and form a spatially dense, three dimensional structure. A first current collector is in communication with the first non-planar channel and forms a first electrode, while a second current collector is in communication with the second non-planar channel and forms a second electrode. A separator layers separates the current collectors.
Abstract:
Substituted cyclopropyl compounds of the formula I: and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing type 2 diabetes and similar conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR-119. Pharmaceutical compositions and methods of treatment are also included.
Abstract:
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Abstract:
The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.
Abstract:
The present invention provides a dye-sensitized solar cell which can obtain a high photoelectric conversion efficiency, which can be manufactured at a low cost, and which is superior in a design property, and a method of manufacturing the same. Dye supporting porous titanium oxide layers 2a to 2d are formed on a transparent conductive substrate 1 so as to display predetermined colors, respectively, and compose predetermined patterns, respectively, in accordance with selection of a thickness, a lamination structure, a particle diameter of titanium oxide fine particles, or a combination ratio of two or more kinds of titanium oxide fine particles when titanium oxide fine particles are composed of the two or more kinds of titanium oxide fine particles different in particle diameter from one another. The transparent conductive substrate 1 having the dye supporting porous titanium oxide layers 2a to 2d formed thereon, and a transparent conductive substrate 3 having a counter electrode 4 formed thereon are stuck to each other through a seal material 5 so that the dye supporting porous titanium oxide layers 2a to 2d, and the counter electrode 4 face each other, and a space defined between the transparent conductive substrate 1 and the transparent conductive substrate 3 is enclosed with an electrolyte layer 6, thereby forming a dye-sensitized solar cell.
Abstract:
Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R , such as obesity, and diabetes.
Abstract:
Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
Abstract:
Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1R, such as obesity, and diabetes.
Abstract:
The present invention relates to a method of manufacturing a photoelectric conversion device in which selective dye adsorption can be performed easily. In the step of a dye adsorbing process, a material unit 21 having partition walls of a predetermined shape is placed over semiconductor electrodes 121 to 123, which are a titanium oxide electrode. The material unit 21 is laminated by a UV cure adhesive. Dye solutions S1 to S3 obtained by dissolving each of three kinds of dyes of N719, Black dye, and D149, for example, into a CH3CN/t-BuOH mixed solution are put in each of sections divided by the partition walls. The material unit 21 is inverted in that state, and left standing still for 24 hours. Then, the adhesive is removed after passage of the 24 hours. Thus, the semiconductor electrodes 121 to 123 having regions corresponding to the sections which regions are colored with the three different kinds of dyes are obtained. The present invention is applicable to a method of manufacturing a dye sensitized solar cell.